U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07033182) titled 'Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment' on June 13.
Brief Summary: To evaluate the pharmacokinetics and safety of a single intravenous dose of levornidazole disodium phosphate for injection in subjects with moderate and severe renal impairment and healthy subjects.
Study Start Date: Oct. 30, 2023
Study Type: INTERVENTIONAL
Condition:
Infections Caused by Anaerobic Bacteria
Renal Impairment
Intervention:
DRUG: Levornidazole Disodium Phosphate for Injection
Single dose, IV
Recruitment Status: COMPLETED
Sponsor: Yangtze R...